Bio2040 - Bottlenecks & Future of Healthcare & Drug Discovery
Share:
Listens: 273
About
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of drug discovery by speaking with some of the sharpest, most innovative minds in drug discovery, biotechnology and related fields. We talk about machine learning for high-throughput screening, open source drug discovery and other trends that are changing how drug discovery gets done.
What are the main challenges in translating scientific innovation from the bench-side to the bedside? Physician and long-term Pharma executive Nadine ...
SEED2019 is a scrappy conference targeting innovation within the science publishing & funding process. It will bring together a diverse set of stakeho...
How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not f...
Peer review is opaque and a large frustration for many scientists. Preprints are becoming more prevalent, but we still need to assess them critically....
Oskari and Flavio talk about how robots can help humans in biomedical research. UniteLabs is building lab automation systems to automate boring tasks ...
What does Open Research mean for the Gates Foundation? Why does it matter? How are they implementing it? We speak with Ashley Farley who is in charge ...
In the 2nd part of the interview with Prof. Ernst Hafen we learn about how the birth of the Bio-Technopark Schlieren shows that if innovative entrepre...
Lenny is the founder and CEO of protocols.io, where scientists can freely share scientific protocols with each other. Similarly to github, others can ...
In this episode, Prof. Ernst Hafen from ETH Zurich tells us how citizens can play a very important role in biomedical research and drug discovery. Rec...
In this episode, we learn how Huntington's disease researcher Rachel Harding uses an open lab notebook to share her findings with the scientific commu...